Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Myeloid 1

Conditions

Pancreatic Neoplasms 2Genetic Predisposition to Disease 1Gallbladder Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Mutation × Gastrointestinal × Clear all
NCT05657210 2022-12-20

Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer

Seoul National University Bundang Hospital

Completed
2,203 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05604573 2022-11-03

DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

Seoul National University Hospital

Unknown
150 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03982446 2021-02-12

PaMPA

Hellenic Cooperative Oncology Group

Completed
549 enrolled
Gastrointestinal

Pancreatic Neoplasms, Genetic Predisposition to Disease

NCT03772132 2018-12-11

Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
100 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡